A smoking-prevention strategy that targets black fourth-graders and their parents is under study in urban and rural Georgia.

A new study shows that obstacles to smoking cessation and motives for quitting smoking vary with age. The study presented at CHEST 2007, the 73rd annual international scientific assembly of the American College of Chest Physicians (ACCP), found that smokers over age 65 reported quitting smoking due to physician pressure and stress due to a major health problem, while smokers under age 65 reported cigarette cost and tobacco odor as reasons for quitting.

Hospitalized patients who smoke may be more likely to quit smoking through the use of hypnotherapy than patients using other smoking cessation methods.

Mark Twain boasted that it was easy to quit smoking because he did it every day. We now may have the beginnings of understanding why some people find it so difficult to stop smoking even when they are in treatment for this problem.

Whether a smoking-cessation drug will enable you to quit smoking may depend on your genes, according to new genotyping research from the Centre for Addiction and Mental Health (CAMH). The study, published in the September issue of the journal Biological Psychiatry, found that the enzyme known to metabolize both the smoking cessation drug bupropion and nicotine is highly genetically variable in all ethnicities and influences smoking cessation.

A genetic variant present in nearly half of Americans of European ancestry is linked to greater effectiveness of the smoking cessation medication bupropion (Zyban), according to research by scientists supported by the National Institute on Drug Abuse (NIDA) and the National Cancer Institute (NCI), part of the National Institutes of Health (NIH).

A study from the Monell Chemical Senses Center reports that nicotine in the breast milk of lactating mothers who smoke cigarettes disrupts their infants' sleep patterns.

The more magazine ads smokers see for the nicotine patch and other quit-smoking aids, the more likely they are to try to quit smoking and be successful - even without buying the products, finds a new Cornell study.

Hospitalized patients make a great captive audience for smoking cessation efforts, according to a new systematic review.

Now Viewed as a Mainstream Healthcare Market, Smoking Cessation Drugs Set to Reach $1.5 Billion. Demand Factors, Emerging Products Analyzed by Applied Data Research.

Increasing cigarette taxes is an effective strategy for reducing tobacco use but there may be negative consequences especially in disadvantaged minority communities. According to a study conducted by researchers at Columbia University Mailman School of Public Health, a dramatic rise in illegal street sales of untaxed cigarettes was reported among minority low-income persons immediately after the price increase that reinforced smoking and undermined cessation efforts.

Despite tried and true methods to quit smoking, young adults do not take advantage of these proven smoking cessation treatments that can double their chances of quitting, University of Illinois at Chicago public health researchers report.